[HTML][HTML] Aggressive Cushing's disease: molecular pathology and its therapeutic approach

M Yamamoto, T Nakao, W Ogawa… - Frontiers in …, 2021 - frontiersin.org
Cushing's disease is a syndromic pathological condition caused by adrenocorticotropic
hormone (ACTH)-secreting pituitary adenomas (ACTHomas) mediated by …

[HTML][HTML] Aggressive Cushing's Disease: Molecular Pathology and Its Therapeutic Approach

M Yamamoto, T Nakao, W Ogawa… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Cushing's disease is a syndromic pathological condition caused by adrenocorticotropic
hormone (ACTH)-secreting pituitary adenomas (ACTHomas) mediated by …

Aggressive Cushing's Disease: Molecular Pathology and Its Therapeutic Approach

M Yamamoto, T Nakao, W Ogawa… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Cushing's disease is a syndromic pathological condition caused by adrenocorticotropic
hormone (ACTH)-secreting pituitary adenomas (ACTHomas) mediated by …

Aggressive Cushing's Disease: Molecular Pathology and Its Therapeutic Approach

M Yamamoto, T Nakao, W Ogawa… - Refractory Pituitary …, 2022 - books.google.com
Cushing's disease is a hypercortisolemic state caused by adrenocorticotropic hormone
(ACTH)-secreting pituitary adenomas (ACTHomas). Although most ACTHomas can be …

Aggressive Cushing's Disease: Molecular Pathology and Its Therapeutic Approach

山本, 小川, 渉,福岡, 秀規 - Frontiers in Endocrinology, 2021 - cir.nii.ac.jp
抄録 Cushing's disease is a syndromic pathological condition caused by adrenocorticotropic
hormone (ACTH)-secreting pituitary adenomas (ACTHomas) mediated by …

Aggressive Cushing's Disease: Molecular Pathology and Its Therapeutic Approach.

M Yamamoto, T Nakao, W Ogawa… - Frontiers in …, 2021 - europepmc.org
Cushing's disease is a syndromic pathological condition caused by adrenocorticotropic
hormone (ACTH)-secreting pituitary adenomas (ACTHomas) mediated by …